Cardiology
News, opinions and meeting coverage in cardiology.
— "We've got to find a better pathway to be involved"
Latest in Cardiology
Cost less of a deciding factor in evolving market
Also in TTHealthWatch: an antibody to reduce bleeding risk in those with Afib
Early cases may be driven by increased surveillance
Phase IIb trial strongly favors safety of novel agent over DOAC, but stroke impact still unclear
Early cases may be driven by increased surveillance
Phase IIb trial strongly favors safety of novel agent over DOAC, but stroke impact still unclear
Cardiology Case Studies
ECG findings clarify those of a thorough physical and patient history
Symptom resolution after stopping anti-HER2 therapy suggests treatment-related cardiotoxicity
Idiopathic ventricular fibrillation can affect people with no clinical evidence of heart disease
More in Cardiology
Real-world data on empagliflozin, canagliflozin, and dapagliflozin
Recent developments of interest in cardiovascular medicine
Findings represent "a hopeful message that early intervention truly matters," researcher says
VA researchers found lower risks for 42 diverse outcomes and increased risks for 19 others
Also in TTHealthWatch: improving outcomes in large strokes
And 40.5% noted efficacy claims not listed on the labels of their originator products
25 drugs chosen so far comprise about a third of Medicare Part D spending on prescription drugs
Dual diagnosis comes with increased risks of mortality, heart failure hospitalization
No disparity emerges, though, in discussing weight-loss surgery with a healthcare provider
Health news and commentary gathered by ѿapp staff
Global commission makes the case to move beyond BMI, incorporate other measures of body fat
Recent developments of interest in cardiovascular medicine
Potential effects on environment and wildlife
